179 related articles for article (PubMed ID: 10741403)
21. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice.
Probert L; Plows D; Kontogeorgos G; Kollias G
Eur J Immunol; 1995 Jun; 25(6):1794-7. PubMed ID: 7615010
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal mesothelial cells produce inflammatory related cytokines.
Yao V; Platell C; Hall JC
ANZ J Surg; 2004 Nov; 74(11):997-1002. PubMed ID: 15550091
[TBL] [Abstract][Full Text] [Related]
23. Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint.
Marinova-Mutafchieva L; Gabay C; Funa K; Williams RO
Clin Exp Immunol; 2006 Nov; 146(2):287-93. PubMed ID: 17034581
[TBL] [Abstract][Full Text] [Related]
24. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Britti D; De Maio M; Caputi AP
Eur Cytokine Netw; 2001; 12(4):568-80. PubMed ID: 11781183
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors.
Hale KK; Smith CG; Baker SL; Vanderslice RW; Squires CH; Gleason TM; Tucker KK; Kohno T; Russell DA
Cytokine; 1995 Jan; 7(1):26-38. PubMed ID: 7749064
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis.
Plater-Zyberk C; Joosten LA; Helsen MM; Sattonnet-Roche P; Siegfried C; Alouani S; van De Loo FA; Graber P; Aloni S; Cirillo R; Lubberts E; Dinarello CA; van Den Berg WB; Chvatchko Y
J Clin Invest; 2001 Dec; 108(12):1825-32. PubMed ID: 11748266
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
[TBL] [Abstract][Full Text] [Related]
28. Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1.
Tada Y; Ho A; Koarada S; Morito F; Ushiyama O; Suzuki N; Kikuchi Y; Ohta A; Mak TW; Nagasawa K
Clin Immunol; 2001 Jun; 99(3):325-33. PubMed ID: 11358427
[TBL] [Abstract][Full Text] [Related]
29. Synergistic effect on the attenuation of collagen induced arthritis in tumor necrosis factor receptor I (TNFRI) and interleukin 6 double knockout mice.
Yamaguchi N; Ohshima S; Umeshita-Sasai M; Nishioka K; Kobayashi H; Mima T; Kishimoto T; Saeki Y
J Rheumatol; 2003 Jan; 30(1):22-7. PubMed ID: 12508385
[TBL] [Abstract][Full Text] [Related]
30. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis.
Jeong JG; Kim JM; Ho SH; Hahn W; Yu SS; Kim S
J Gene Med; 2004 Oct; 6(10):1125-33. PubMed ID: 15452879
[TBL] [Abstract][Full Text] [Related]
31. Expression of Fas ligand improves the effect of IL-4 in collagen-induced arthritis.
Guéry L; Batteux F; Bessis N; Breban M; Boissier MC; Fournier C; Chiocchia G
Eur J Immunol; 2000 Jan; 30(1):308-15. PubMed ID: 10602054
[TBL] [Abstract][Full Text] [Related]
32. Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice.
Li H; Gong X; Zhang L; Zhang Z; Luo F; Zhou Q; Chen J; Wan J
Phytomedicine; 2009 Jun; 16(6-7):538-46. PubMed ID: 19135346
[TBL] [Abstract][Full Text] [Related]
33. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor.
Piguet PF; Grau GE; Vesin C; Loetscher H; Gentz R; Lesslauer W
Immunology; 1992 Dec; 77(4):510-4. PubMed ID: 1337334
[TBL] [Abstract][Full Text] [Related]
34. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
Tomita T; Kakiuchi Y; Tsao PS
Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
[TBL] [Abstract][Full Text] [Related]
35. Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1.
Penton Rol G; Polentarutti N; Sironi M; Saccani S; Introna M; Mantovani A
Eur Cytokine Netw; 1997 Sep; 8(3):265-9. PubMed ID: 9346359
[TBL] [Abstract][Full Text] [Related]
36. Toxic shock syndrome toxin-1 accelerated collagen-induced arthritis in mice.
Kageyama Y; Koide Y; Nagata T; Uchijima M; Yoshida A; Arai T; Miura T; Miyamoto C; Nagano A
J Autoimmun; 2001 Mar; 16(2):125-31. PubMed ID: 11247638
[TBL] [Abstract][Full Text] [Related]
37. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
Mullazehi M; Mathsson L; Lampa J; Rönnelid J
Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
[TBL] [Abstract][Full Text] [Related]
38. [Effect of interleukin I receptor antigonist gene therapy on arthritis induced by type II collagen in mice].
Yang G; Di C; Jiang M; Li F; Zhang Y; Yuan L; Song Q; Ma D
Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):990-4. PubMed ID: 12181096
[TBL] [Abstract][Full Text] [Related]
39. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
[TBL] [Abstract][Full Text] [Related]
40. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
